Tokyo, Dec. 25 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060189) titled 'A study to investigate the impact of new oral and injectable treatments for atopic dermatitis on patients, their families, and healthcare costs' on Dec. 24.
Study Type:
Observational
Primary Sponsor:
Institute - Mie National Hospital
Condition:
Condition - Atopic dermatitis
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - This study aims to evaluate the societal value of novel systemic therapies for atopic dermatitis through comprehensive health economic assessment. In particular, the study will quantitatively assess caregiver burden, including loss of work product...